a potent gonadotropin releasing hormone ( gnrh ) agonist , d ( nal2 ) 6 gnrh ( nafarelin ) has been administered to two groups of normal men for 16 weeks by two routes in order to assess its effectiveness in suppressing spermatogenesis .
C0023610
gnrh
C0064906
nafarelin